Group 6 Copy 656
0
    Please wait...

    About This Project

    The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Dermatology AI Assistant to Empower Primary Care Providers in Zaatari Refugee Camp in Jordan

    An AI-assisted dermatology tool for refugees, utilizing imaging and symptom questionnaires to improve diagnostic...

    The Dogs of Chernobyl Research Initiative

    The Chernobyl disaster site has hundreds of feral dogs that are in need of care. A team of students from...

    Improving Collaborations for Neglected Tropical Diseases

    Neglected tropical diseases (NTDs) infect over a billion of the poorest people in the world, yet only a...

    Backer Badge Funded